In particular, inhibition of NAF-1 expression can enhance pancreatic cancer cell sensitivity to gemcitabine, demonstrating the function of NAF-1 in the chemoresistance of pancreatic cancer cells. Here, NAF1 is linked to pancreatic neoplasm.